GSA Capital Partners’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60K | Buy |
+13,894
| New | +$60K | ﹤0.01% | 1651 |
|
|
2025
Q1 | – | Sell |
-106,562
| Closed | -$1.08M | – | 1877 |
|
|
2024
Q4 | $1.08M | Sell |
106,562
-11,818
| -10% | -$120K | 0.08% | 360 |
|
|
2024
Q3 | $1.47M | Buy |
118,380
+52,819
| +81% | +$658K | 0.11% | 228 |
|
|
2024
Q2 | $853K | Sell |
65,561
-21,049
| -24% | -$274K | 0.06% | 611 |
|
|
2024
Q1 | $1.96M | Sell |
86,610
-69,256
| -44% | -$1.57M | 0.16% | 112 |
|
|
2023
Q4 | $2.02M | Buy |
155,866
+117,979
| +311% | +$1.53M | 0.17% | 114 |
|
|
2023
Q3 | $762K | Buy |
+37,887
| New | +$762K | 0.07% | 543 |
|
|
2023
Q1 | – | Sell |
-5,477
| Closed | -$279K | – | 1707 |
|
|
2022
Q4 | $279K | Buy |
+5,477
| New | +$279K | 0.03% | 978 |
|
|
2022
Q1 | – | Sell |
-12,798
| Closed | -$1.23M | – | 1626 |
|
|
2021
Q4 | $1.23M | Buy |
12,798
+998
| +8% | +$96.2K | 0.16% | 131 |
|
|
2021
Q3 | $1.03M | Buy |
11,800
+9,857
| +507% | +$860K | 0.1% | 301 |
|
|
2021
Q2 | $301K | Sell |
1,943
-96
| -5% | -$14.9K | 0.03% | 944 |
|
|
2021
Q1 | $322K | Buy |
2,039
+579
| +40% | +$91.4K | 0.05% | 597 |
|
|
2020
Q4 | $339K | Buy |
+1,460
| New | +$339K | 0.06% | 672 |
|